Back close

Concurrent chemoradiotherapy for head and neck cancers in older patients: Outcomes and their determinants

Publication Type : Scientific reports

Publisher : National library of Medicine

Source : Indian J Cancer. 2019 Jul-Sep;56(3):261-266. doi: 10.4103/ijc.IJC_725_18. PMID: 31389391.

Url : https://pubmed.ncbi.nlm.nih.gov/31389391/

Campus : Kochi

School : School of Medicine

Year : 2019

Abstract : Meta-analyses have shown concurrent chemoradiotherapy (CCRT) provides no survival benefit over radiotherapy in patients of head and neck squamous cell carcinoma (HNSCC) aged over 70 years. This study was performed to determine the adverse-effect profile, compliance, functional and oncological outcomes in patients of HNSCC over 70 years of age treated with CCRT.

Cite this Research Publication : Srinivasalu VK, Subramaniam N, Balasubramanian D, Kumar N, Philip A, Susan A, Pushpaja KU, Nair AR, Thankappan K, Jose W, Iyer S, Keechilat P. Concurrent chemoradiotherapy for head and neck cancers in older patients: Outcomes and their determinants. Indian J Cancer. 2019 Jul-Sep;56(3):261-266. doi: 10.4103/ijc.IJC_725_18. PMID: 31389391.

Admissions Apply Now